Arcus Biosciences Overview

  • Founded
  • 2015
Founded
  • Status
  • Public
  • Employees
  • 236
Employees
  • Stock Symbol
  • RCUS
Stock Symbol
  • Share Price
  • $30.13
  • (As of Thursday Closing)

Arcus Biosciences General Information

Description

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB680, and Zimberelimab. Arcus conducts clinical trials for different types of cancers such as Prostate, Lung, Colorectal, Pancreatic, and others. The company operates through the single segment being the business of developing and commercializing immunotherapies.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
NYS
Primary Office
  • 3928 Point Eden Way
  • Hayward, CA 94545
  • United States
+1 (510) 000-0000

Arcus Biosciences Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Arcus Biosciences Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$30.13 $30.94 $16.69 - $42.36 $2.14B 71M 528K -$2.80

Arcus Biosciences Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 1,276,801 902,977 272,187 220,930
Revenue 85,228 77,517 15,000 8,353
EBITDA (164,039) (120,044) (86,333) (50,852)
Net Income (167,698) (122,858) (84,710) (49,594)
Total Assets 935,119 772,292 203,110 274,925
Total Debt 14,706 15,243 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Arcus Biosciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Arcus Biosciences‘s full profile, request access.

Request a free trial

Arcus Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Arcus Biosciences‘s full profile, request access.

Request a free trial

Arcus Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of ca
Biotechnology
Hayward, CA
236 As of 2020
00000
000000000 00000

0000 000

iquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum
0000 000000000
South San Francisco, CA
00 As of 0000
00000
00000000 00000

00000000

qua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commod
0000000000000
Gaithersburg, MD
00 As of 0000
00000
0000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Arcus Biosciences Competitors (21)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
RAPT Therapeutics Formerly VC-backed South San Francisco, CA 00 00000 00000000 00000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000
00000000 Venture Capital-Backed San Carlos, CA 00 00000 00000000000 00000
000000 00000000000 Formerly VC-backed Burlingame, CA 00 00000 000000 - 000 00000
You’re viewing 5 of 21 competitors. Get the full list »

Arcus Biosciences Executive Team (17)

Name Title Board Seat Contact Info
Bob Goeltz Chief Financial Officer
Jennifer Jarrett Chief Operating Officer, Operations & Board Member
Eric Matthews Chief Commercial Officer
Juan Jaen Ph.D Founder & Board Member
Yvonne Gehring Vice President, Human Resources & Operations
You’re viewing 5 of 17 executive team members. Get the full list »

Arcus Biosciences Board Members (11)

Name Representing Role Since
David Beier JD Self Board Member 000 0000
David Lacey MD Arcus Biosciences Board Member 000 0000
Jennifer Jarrett Arcus Biosciences Chief Operating Officer, Operations & Board Member 000 0000
Juan Jaen Ph.D Arcus Biosciences Founder & Board Member 000 0000
Kathryn Falberg Self Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Arcus Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Arcus Biosciences Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Arcus Biosciences‘s full profile, request access.

Request a free trial